Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
Linkedin
Twitter

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission
TELCORE Revenue Cycle Management

Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission
Linkedin
Twitter

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Day: November 12, 2020

As Flu Season Approaches, FDA Provides Clinical Laboratories Flexibility to Modify Influenza and RSV Tests

FDA maze of regulations

Breakout of examples of modifications that will and will not be permitted with influenza and RSV clinical lab tests during the public health emergency.

More COVID-19 Coverage Can Be Found in THE DARK REPORT
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Live Calls
  • Testing Data
  • Resources
  • Mission

Copyright 2020 © The Dark Report. All rights reserved. The Dark Intelligence Group • 21806 Briarcliff Dr • Spicewood, TX 78669

  • Phone: 512-264-7103
Linkedin
Twitter